Inside Precision Medicine May 17, 2023
Chris Anderson

Looking to deepen its services to the pharmaceutical and biotech industry, Google Cloud announced Tuesday at Bio-IT World Conference in Boston, the debut of two AI-powered research suites—one for target and lead identification and another multiomics. The Target and Lead Identification Suite will help researchers understand the function of amino acids and serve as a predictive engine for the structure of proteins, while the Multiomics Suite will help researchers analyze large and diverse sets of omics data aimed at developing precision treatments.

“We’ve long been involved with creating new tools for understanding and working with the code of life, like high performance computing for genomic analytics, and artificial intelligence that can predict three-dimensional models of proteins,” said Shweta...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Cloud, Conferences / Podcast, Health IT, Pharma, Pharma / Biotech, Technology, Trends
FTC eyes Microsoft’s cloud practices amid antitrust scrutiny
Tech giants are investing in 'sovereign AI' to help Europe cut its dependence on the U.S.
5 Ways Healthcare Organizations Can Get the Most Out of a Cloud Assessment
Oracle seeks to address health disparities with new collaborative
Amazon vs. Microsoft cloud with Epic: 6 notes

Share This Article